Reitz et al. show that targeting the circadian regulator REV-ERB for just one day after myocardial ischemia-reperfusion benefits cardiac repair by reducing the NLRP3 inflammasome and immune recruitment to infarcted myocardium, and thus preventing the development of heart failure. This evidence concerns the gene NLRP3 and heart failure.